3 completed, 2 recruiting, 1 unknown, 1 withdrawn. 3 Not applicable, 2 Phase 4, 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 3 | Recruiting 1, Unknown 1, Withdrawn 1 |
| Phase 4 | 2 | Completed 1, Recruiting 1 |
| Phase 2 | 1 | Completed 1 |
| Phase 3 | 1 | Completed 1 |
Follow Osteoporosis Postmenopausal: new trials by email Literature Review of Osteoporosis Postmenopausal trials Research Report on Osteoporosis Postmenopausal
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Telerehabilitation Versus Traditional Balance Training in Women With Osteoporosis. Telerehabilitation group, Traditional balance training group - Osteoporosis Postmenopausal | Not applicable | Withdrawn | Riphah International University | 2026-01-01 | 2026-08-27 | |
| Effect of Mechanical Loading and Bone Loss on Motor Neuron Activity-H-Reflex Relationship H-reflex, Bone myoregulation reflex - Osteoporosis Postmenopausal | Not applicable | Recruiting | Istanbul Physical Medicine Rehabilitation Training and Research Hospital | 24 | 2025-11-18 | 2025-11-28 |
| Effects of Cycle Therapy vs Sequential Therapy With Romosozumab and Denosumab in Postmenopausal Osteoporosis Patients Romosozumab followed by Denosumab, Romosozumab and Denosumab Cycle Therapy - Osteoporosis, Osteoporosis Postmenopausal | Phase 4 | Recruiting | National Taiwan University Hospital | 70 | 2025-04-08 | 2026-06-23 |
| Effects of Time-restricted Eating and Exercise Training on Skeletal Muscle Mass Quantity, Quality and Function in Postmenopausal Women With Overweight and Obesity Time Restricted Eating (TRE), Exercise, Caloric Restriction - Menopause Related Conditions, Sarcopenia | Not applicable | Unknown | Idoia Labayen | 78 | 2023-09-01 | 2024-04-17 |
| Efficacy and Safety Study of Fosamax Plus D in Postmenopausal Women With Osteoporosis (0217A-263) alendronate sodium (+) cholecalciferol, Comparator: Alendronate sodium (Fosamax), Comparator: Calcium - Osteoporosis Postmenopausal | Phase 4 | Completed | Organon and Co | 343 | 2008-03-20 | 2024-04-23 |
| Efficacy and Safety of Odanacatib (MK-0822) in Participants With Involutional Osteoporosis (MK-0822-022) Odanacatib, Vitamin D3, Calcium carbonate - Osteoporosis Postmenopausal | Phase 2 | Completed | Merck Sharp & Dohme LLC | 287 | 2007-12-03 | 2018-08-27 |
| Risedronate 75mg Dosed on 2 Consecutive Days Monthly in the Treatment of Osteoporosis in Postmenopausal Women Risedronate (HMR4003) - Osteoporosis Postmenopausal | Phase 3 | Completed | Sanofi | 1231 | 2004-07-01 | 2009-12-15 |
Osteoporosis, Postmenopausal (7) · Osteoporosis (4) · Fatty Liver (1) · Motor Activity (1) · Obesity (1) · Overweight (1) · Sarcopenia (1)
Bone Diseases (7) · Bone Diseases, Metabolic (7) · Metabolic Diseases (7) · Musculoskeletal Diseases (7) · Nutritional and Metabolic Diseases (7) · Osteoporosis (3) · Atrophy (1) · Behavior (1) · Body Weight (1) · Digestive System Diseases (1) · Liver Diseases (1) · Muscular Atrophy (1) · Nervous System Diseases (1) · Neurologic Manifestations (1) · Neuromuscular Manifestations (1)
Cholecalciferol (2) · Alendronate (1) · Calcium Carbonate (1) · Caloric Restriction (1) · Exercise (1) · Fumigant 93 (1) · H-Reflex (1) · Risedronic Acid (1) · odanacatib (1) · romosozumab (1)
Idoia Labayen (1) · Istanbul Physical Medicine Rehabilitation Training and Research Hospital (1) · Merck Sharp & Dohme LLC (1) · National Taiwan University Hospital (1) · Organon and Co (1) · Riphah International University (1) · Sanofi (1)
Turkey (Türkiye) (2) · Argentina (1) · Australia (1) · Canada (1) · Czechia (1) · France (1) · Lebanon (1) · Pakistan (1) · Poland (1) · South Africa (1) · Spain (1) · Taiwan (1) · United Kingdom (1) · United States (1)
Estrella Petrina, PhD (1) · Idoia Labayen, PhD (1) · Prof. Dr. Huma Riaz (1)
PMID 11138687, PMID 24719139, PMID 27641143, PMID 28144701, PMID 29067572, PMID 35279261, PMID 35478046, PMID 35787482, PMID 36088628, PMID 36382762, PMID 37574339, PMID 37948565, PMID 39485918